Using CPPs to disrupt the GLT-1/PS1 interaction, we confirmed that the GLT-1/PS1 binding is necessary for the GLT-1-mediated effects on Aβ levels, implicating the relevance of the GLT-1/PS1 interaction in AD. Here, SLC1A2 is linked to Alzheimer disease.